First treatment for rare enzyme disorder.
D017277:Drug Approval; D006801:Humans; D007068:Iduronidase / Q000627:therapeutic use*; D008059:Mucopolysaccharidosis I / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D007068:Iduronidase